[DarioHealth in PR Newswire] Dario publishes new peer-reviewed study that deepens the body of evidence that managing cardiometabolic conditions in one integrated platform improves clinical outcomes

NEW YORK, April 25, 2024 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, announced today new research published in the leading peer-reviewed journal for digital health and medicine, Journal of Internet Medicine (JMIR) demonstrating a clinically significant reduction in blood glucose levels for members using Dario to manage weight alongside diabetes.

Read more here.